Characterization of Protein Therapeutics using Mass Spectrometry
Produktdetaljer
Biografisk notat
Dr. Guodong Chen has extensive pharmaceutical research experience in major pharmaceutical companies, including Eli Lilly, Schering-Plough (now Merck) and Bristol-Myers Squibb. He is currently heading a mass spectrometry group at Bristol-Myers Squibb's Princeton site, providing mass spectrometric/analytical support to drug discovery and development programs in small molecule pharmaceuticals and biologics. He has over 45 research publications in peer-reviewed journals and 9 book chapters covering the broad area of mass spectrometry and analytical sciences. He has co-edited two books: "Characterization of Impurities and Degradants Using Mass Spectrometry" and "Mass Spectrometry of Proteins/Peptides in Drug Discovery" (respectively 2010 and forthcoming). He is a short course instructor for two short courses on "LC/MS: Theory, Instruments and Applications" and "Practical Solutions to Characterization of Protein Therapeutics Using Mass Spectrometry" at Eastern Analytical Symposium.Protein therapeutics’ high efficacy, safety, and ability to treat life-threatening diseases such as cancer, inflammation and genetic disorders have revolutionized modern medicine. In 2012, 200 companies competed in this $90 billion year industry.
In Characterization of Protein Therapeutics using Mass Spectrometry, expert contributors from academia and industry highlight current approaches and future trends. The book discusses mass spectrometry techniques as related to the analysis of protein therapeutics, structural identification strategies and quantitative approaches. The book also covers various studies involving characterization of process related protein drug impurities/degradants, metabolites, PTMs and higher order structures of protein therapeutics.
General practitioners in pharmaceutical research, specialists in analytical sciences, and graduate students studying mass spectrometry and pharmaceutical sciences will find this book useful because of the step-by-step approaches and new strategies to solve challenging problems related to protein therapeutics research and development.